Non-Invasive Prenatal Testing (NIPT) in the UAE

Non-Invasive Prenatal Testing (NIPT) in the UAE is available at the Mediclinic MFM Units (Abu Dhabi & Al Ain Hubs) MFM Unit from 10 completed weeks. It is a maternal blood screening test for trisomies 21, 18, and 13. Performance varies by condition, laboratory, and population; a high-risk result requires diagnostic confirmation.

Who This Page is For

Customized clinical pathways and insights to support our patients and referring medical partners.

Pregnant Patient

Expectant mothers from 10 completed weeks seeking screening for common chromosomal conditions without an invasive procedure.

Referring Doctor

Obstetricians seeking reliable risk stratification for chromosomal aneuploidies using cell-free DNA (cfDNA).

Abnormal Screening

Mothers with an increased-chance or inconclusive screening result who need counselling about cfDNA screening and diagnostic options.

Second Opinion

Parents wanting to discuss screening accuracy, options, and abnormal results with MFM experts.

When to see MFM

Available to all pregnant patients from 10 completed weeks after counselling about the available screening and diagnostic options.
Mothers wishing to screen for common trisomies using a maternal blood sample.
Borderline or elevated risk results on first-trimester combined screening.
Family history of chromosomal abnormalities.

What we do

Pre-test clinical counseling to explain testing limitations and capabilities.
Maternal venipuncture blood draw performed starting from 10 completed weeks.
Next-Generation Sequencing (NGS) analysis of cell-free fetal DNA.
Post-test consultation to discuss results and direct diagnostic pathways if high-risk.

What happens during the visit

1

Consultation with the MFM specialist to review gestational age and indicators.

2

A simple maternal blood draw.

3

Laboratory processing; the expected turnaround depends on the test and laboratory and is confirmed when the sample is taken.

4

Review of results with the clinical team, in-person or via telehealth.

When urgent referral is needed

  • High-risk NIPT result indicating Down, Edwards, or Patau syndrome requires prompt MFM consultation for diagnostic options.
  • NIPT cannot replace diagnostic tests; positive results must be confirmed.

Where the service is available

Available across Mediclinic MFM hubs in Abu Dhabi (Airport Road Hospital) and Al Ain (Al Jowhara Hospital), with referral pathways coordinating care for patients nationwide.

Why Fetus.ae / Mediclinic MFM

Fully integrated pre- and post-test counseling by fellowship-trained MFM specialists.
Access to CVS or amniocentesis when diagnostic confirmation is clinically appropriate, after individual counselling.
Clinical genetics laboratory partners selected for the test required.
Comprehensive ultrasound scan performed at the time of blood draw to verify viability and dating.

Mediclinic UAE Maternal Fetal Medicine Unit

Appointments & Inquiries

800 2000

Clinical Working Hours

Clinic times vary by location and consultant. Please confirm when booking via 800 2000.

Specialists Available

Explore each doctor’s qualifications, clinical interests and verified practice location.

Dr. Ali Al-Ibrahim

Dr. Ali Al-Ibrahim

Head of Unit · Consultant Maternal–Fetal Medicine

Toronto fellowship training and more than 25 years of experience, bringing together fetal diagnosis, maternal medicine and coordinated care.

View Full Profile
Dr. Leanne Bricker

Dr. Leanne Bricker

Consultant Maternal–Fetal Medicine

Extensive experience in fetal therapy and complex multiple pregnancy, alongside international contributions to research and clinical guidance.

View Full Profile
Dr. Werner Diehl

Dr. Werner Diehl

Consultant Maternal–Fetal Medicine

Our team’s most experienced fetal therapist, bringing broad expertise across fetal therapies, advanced fetal surgery and complex twin pregnancy.

View Full Profile
Dr. Soha Tohamy Said

Dr. Soha Tohamy Said

Consultant Maternal–Fetal Medicine & Obstetrics and Gynecology

More than 28 years of clinical and leadership experience, with particular interests in maternal health and prevention of preterm birth.

View Full Profile
Dr. Gareth James Waring

Dr. Gareth James Waring

Consultant Maternal–Fetal Medicine

Extensive fetal therapy and surgery experience, alongside expertise in fetal heart conditions and prevention of preterm birth.

View Full Profile
Dr. Bernard Nasr

Dr. Bernard Nasr

Consultant Obstetrics and Gynecology · Fetal Medicine

Training in France and Spain, with clinical interests in fetal therapy, growth problems and complex twin pregnancy.

View Full Profile
Dr. Marija Hadji Lega

Dr. Marija Hadji Lega

Specialist Maternal–Fetal Medicine · Associate Professor

More than 25 years of clinical experience, combining advanced fetal imaging with academic teaching and clinical leadership.

View Full Profile
Dr. Najwa Ibrahim

Dr. Najwa Ibrahim

Consultant Maternal–Fetal Medicine

Care for complex pregnancies, with interests in advanced ultrasound, prenatal screening, fetal growth and placental health.

View Full Profile
Dr. Howaida Khair

Dr. Howaida Khair

Consultant Obstetrics and Gynecology

A seasoned obstetrician and gynecologist with a special interest in fetal medicine, prenatal ultrasound and counselling.

View Full Profile

Frequently Asked Questions

Clinical answers directly from our specialists to help prepare you for your appointment.

It screens for the most common chromosomal trisomies: Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), as well as sex chromosome variations.

NIPT uses a standard maternal blood sample and does not involve entering the pregnancy, so it does not add the procedure-related miscarriage risk associated with invasive sampling.

For trisomy 21, many validated tests report detection above 99% in appropriate populations. Performance varies by condition and laboratory, and the positive predictive value depends on prior risk. NIPT remains screening, not diagnosis.

Yes, NIPT can determine the fetal gender with high accuracy from 10 weeks of pregnancy.

A high-risk result indicates a high probability that the baby has a chromosomal condition. It is not a definitive diagnosis and must be confirmed via CVS or amniocentesis.

A low-risk result is highly reassuring and means the chance of the screened chromosomal conditions is extremely low, though it does not rule out all genetic issues.

Getting Here & Access

Our two hubs cover the country: Mediclinic Airport Road Hospital in Abu Dhabi and Mediclinic Al Jowhara Hospital in Al Ain. Patients from Dubai, Sharjah, Ajman and the Northern Emirates typically attend the Abu Dhabi hub, while Al Ain and Eastern Region families are seen locally. Referrals are coordinated so travel is minimised and, wherever possible, imaging, counselling and any procedure are grouped into as few visits as possible.

Insurance & Coverage

Across both hubs we work with major UAE insurers including Daman (Thiqa and Enhanced), ADNIC, Nextcare, NAS and other networks. Coverage and pre-authorisation vary by plan and emirate, so our team confirms eligibility and arranges approvals before you travel. Self-pay packages are available nationwide.

Areas We Serve

Abu DhabiDubaiSharjahAl AinAjmanRas Al KhaimahFujairahUmm Al QuwainWestern RegionEastern Region

Book a Clinical Consultation

Our Maternal Fetal Medicine specialists provide evidence-based assessment, clear counselling, and coordinated care.

Medical Content Reviewed by: Dr. Ali Al-Ibrahim (MFM Director)
Last updated: August 2026